HL Flashcards
Cell type a/w HL
Reed Sternberg
Arises from post-germinal B cells
MC type of “classical”
Nodular sclerosis (70%)
B symptoms in what % of patients
20-50%
Describe Ann Arbor staging
o I – single LN region. o II – 2 or more regions on same side of diaphragm. o III – LN regions on both sides of diaphragm. o IV – noncontiguous
Treatment (firstline)
Early stage: ABVD (doxorubicin, bleomycin,
vinblastine, dacarbazine) for 2-4 cycles +
XRT OR 4-6 cycles alone.
Prognosis (%)
Early stage: Cure rate 85-90%.
Advanced stage: Cure rate ~75%.
Unfavorable factors
- Stage I/II if age >50,
- ESR >50
- B-symptoms+ESR >30
- Extranodal disease, or large mediastinal LAD
- > 2 nodal sites of involvement
Complications for women
Breast Ca if received XRT
Is F&N common?
No, <1%
Is BMBx routine?
No, only if question of diffuse disease
Adriamycin AE are primarily
cardiac
Bleomycine AE are primary
lung, increased risk of PJP
XRT SE
thyroid failure, radiation fibrosis syndrome (head drop)
Treatment (salvage)
RICE:
- Rituxan D1
- Ifosfamide IVB D1-3 with Mesna D2-4 prior to ifosfamide and 3 & 6 hours after
- Carboplatin IVB D2
- Etoposide D1-3
*Neulasta 24-48h following last dose
Isofosfamide primary AE, and what to do to prevent
Hemorrhage cystitis
- UOP >150cc/hr
- Mesna before and after
- Daily Cr monitoring